Sites and roles of phosphorylation of the human cytomegalovirus DNA polymerase subunit UL44  by Silva, Laurie A. et al.
Virology 417 (2011) 268–280
Contents lists available at ScienceDirect
Virology
j ourna l homepage: www.e lsev ie r.com/ locate /yv i roSites and roles of phosphorylation of the human cytomegalovirus DNA polymerase
subunit UL44
Laurie A. Silva 1, Blair L. Strang, Eric W. Lin, Jeremy P. Kamil 2, Donald M. Coen ⁎
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA⁎ Corresponding author at: Department of Biologi
Pharmacology, Harvard Medical School, 250 Longwood
02115, USA. Fax: +1 617 432 3833.
E-mail address: don_coen@hms.harvard.edu (D.M. C
1 Present address: Elizabeth B. Lamb Center for Pedi
Pediatrics, Vanderbilt University School of Medicine, Na
2 Present address: Department of Microbiology and
Molecular and Tumor Virology, Louisiana State Unive
Shreveport, LA 71130, USA.
0042-6822/$ – see front matter © 2011 Elsevier Inc. Al
doi:10.1016/j.virol.2011.06.008a b s t r a c ta r t i c l e i n f oArticle history:
Received 18 March 2011
Returned to author for revision 12 April 2011
Accepted 11 June 2011
Available online 23 July 2011
Keywords:
Human cytomegalovirus
UL44
UL97
Phosphorylation
Nuclear localizationThe human cytomegalovirus DNA polymerase subunit UL44 is a phosphoprotein, but its sites and roles of
phosphorylation have not been investigated. We compared sites of phosphorylation of UL44 in vitro by the
viral protein kinase UL97 and cyclin-dependent kinase 1 with those in infected cells. Transient treatment of
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Human cytomegalovirus (HCMV) is an important human pathogen
that can cause life-threatening disease in immunocompromised
individuals and congenital defects in newborns (Mocarski et al.,
2007). Although there are several antiviral drugs available for the
treatment of HCMV disease, these drugs have disadvantages, such as
toxicities and drug resistance (Biron, 2006). Thus, novel anti-HCMV
compounds that exhibit a distinct mechanism of action, and are safe,
potent and orally bioavailable, are needed. A new drug, maribavir,
which showed promise in early clinical trials (Trofe et al., 2008),
speciﬁcally inhibits the enzymatic activity of the HCMV-encoded
protein kinase, UL97 (Biron et al., 2002). In addition, UL97 is also
important for its ability to phosphorylate, and thus activate ganciclo-
vir, the leading antiviral compound used to treat HCMV infections
(Littler et al., 1992; Sullivan et al., 1992; Talarico et al., 1999).
UL97 is a member of the conserved herpesviral protein kinase
(CHPK) family (reviewed in Gershburg and Pagano, 2008). A subset of
these viral kinases can phosphorylate cyclin dependent kinase (cdk)consensus sites within a number of cellular proteins, suggesting
that these viral kinases may function as cdk mimics (Baek et al.,
2004; Hamirally et al., 2009; Hume et al., 2008; Kawaguchi et al.,
1999; Kawaguchi and Kato, 2003; Kawaguchi et al., 2003; Kuny
et al., 2010; Romaker et al., 2006). Some CHPKs are essential for
viral replication while others are dispensable, often depending on
the cell type studied (Coulter et al., 1993; de Wind et al., 1992;
Gershburg et al., 2007; Heineman and Cohen, 1995; Kamil and Coen,
2007; Kamil et al., 2009; Krosky et al., 2003a; Moffat et al., 1998;
Prichard et al., 1999; Prichard et al., 2005; Tanaka et al., 2005; Wolf
et al., 2001).
Although UL97 is not an essential viral protein, it plays an
important role in productive virus replication. Ablation of UL97,
either genetically or pharmacologically, has been reported variously
to cause defects in viral DNA synthesis, DNA packaging, nuclear egress
of viral capsids, and cytoplasmic secondary envelopment and release
(Azzeh et al., 2006; Biron et al., 2002; Goldberg et al., 2011; Kamil and
Coen, 2007; Kamil et al., 2009; Krosky et al., 2003a; Prichard et al.,
1999; Prichard et al., 2005; Wolf et al., 2001). However, its role
appears to be more important in non-dividing cells than in dividing
cells (Kamil et al., 2009; Prichard et al., 2005), suggesting that cellular
kinases active in dividing cells may partially substitute for UL97 kinase
activity. This notion is consistent with increased antiviral activity
when maribavir is added to cellular kinase inhibitors, including cdk
inhibitors (Chou et al., 2006; Hertel et al., 2007). Moreover, the
activities of cdks, mainly cdk-1, -2, and -9, are required for several
stages of HCMV replication (Bresnahan et al., 1997a; Hertel et al.,
2007; Kapasi and Spector, 2008; Rechter et al., 2009; Sanchez et al.,
2004; Sanchez and Spector, 2006; Tamrakar et al., 2005; Zydek et al.,
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UL97 may also serve as substrates for cellular cdks.
One candidate substrate of UL97 is the HCMV DNA polymerase
accessory subunit UL44, a phosphoprotein that is essential for viral
replication (Alvisi et al., 2009; Appleton et al., 2006; Ertl and Powell,
1992; Gibson, 1983; Loregian et al., 2004a,b; Weiland et al., 1994).
UL44 can be phosphorylated by puriﬁed UL97 in vitro and during
infection, UL97 activity is important for the normal phosphorylation
pattern of UL44 (Krosky et al., 2003b). These data are consistent with
UL44 being a substrate of UL97 during infection, and led to the widely
promulgated hypothesis that UL97-mediated phosphorylation of
UL44 is important for viral DNA synthesis (Jacob et al., 2011; Krosky
et al., 2003; Marschall et al., 2003; Mercorelli et al., 2008; Michel and
Mertens, 2004; Wolf et al., 2001). A corollary hypothesis is that
inhibition of UL97 kinase activity by maribavir affects viral DNA
replication by preventing phosphorylation of UL44 (Krosky et al.,
2003; Marschall et al., 2003; Mercorelli et al., 2008; Michel and
Mertens, 2004; Wolf et al., 2001).
Aside from phosphorylation by UL97, UL44 is very likely to be
phosphorylated by cellular kinases in the infected cell (Krosky et al.,
2003b). Indeed, phosphorylation on serine 413, likely by casein kinase
(CK2), has been reported to enhance the activity of the UL44 nuclear
localization signal (NLS) in transfected cells (Alvisi et al., 2005).
However, the phosphorylation sites of this indispensable viral protein
during infection have not been determined, and no functional
signiﬁcance of the phosphorylation of UL44 for viral replication has
been demonstrated. In this study, we determined sites of phosphor-
ylation of UL44 both from in vitro kinase reactions with UL97 and
cdk1, and from infected cells. We also investigated whether transient
inhibition of UL97 or cdks reduces UL44 phosphorylation during
infection. Finally, we constructed virus mutants with altered sites of
phosphorylation on UL44, and investigated whether these mutations
resulted in changes in viral replication and viral DNA synthesis.
Results
Sites of UL44 phosphorylated by GST-UL97 in vitro
To identify the sites on UL44 phosphorylated by glutathione-S-
transferase (GST) -UL97 in vitro, we ﬁrst optimized our protocols for
purifying UL44 and for phosphorylating it with GST-UL97 (Supplemen-
tary Fig. 1). We then performed a large-scale phosphorylation reaction
in the presence or absence of GST-UL97. The proteins were resolved by
SDS-PAGE and Coomassie stained. The gel from a representative
experiment is shown in Fig. 1A. When UL44 was incubated alone, a
single major UL44 bandwas observed (Fig. 1A, lane 1). When UL44was
incubated with GST-UL97, a second, slower migrating, presumably
hyperphosphorylated form of UL44 was also observed (Fig. 1A, lane 2,
and Supplementary Fig. 1B). Both species of UL44, as well as UL44 in
control reactions, were excised and analyzed by mass spectrometry
(MS) as described in Materials and methods.
Data from three independent experiments using two different MS
facilities were compiled (Table 1, column 2). Coverage of the amino
acid sequence of UL44 ranged from 83 to 95% in the three
experiments. A total of 12 residues in UL44 were positively identiﬁed
as sites of phosphorylation by GST-UL97 (Table 1, column 2; listed as
conﬁrmed). For six phosphopeptides, the phosphorylated residues
could not be positively identiﬁed. Among these six phosphopeptides,
ten additional sites are candidates for phosphorylation. These ten sites
including the two that are most likely to be phosphorylated are listed
in Table 1. No phosphopeptides were recovered in control reactions
lacking GST-UL97 (coverageN84%). A more detailed analysis of these
phosphorylation sites can be found in Supplementary Table 1.
Most of the sites of phosphorylation by GST-UL97 were located
in the C-terminal third (aa 291–433) of the protein. Of the sites
identiﬁed, only S379 has a basic residue at position +5, similar to thepreferred sites of phosphorylation of histone H2B (Baek et al., 2002),
while only S8 and S289 are predicted to be cdk sites (using the
NetPhosK 1.0 software, scoresN0.45) (Blom et al., 2004). Since the
majority of the phosphorylation sites were located in the C-terminus,
we tested whether the N-terminal two-thirds of the protein
(UL44ΔC290) could be phosphorylated by GST-UL97 in vitro. We
found that UL44ΔC290 was phosphorylated by GST-UL97 (Fig. 1B,
lane 13) in a maribavir-sensitive manner (lane 14), but to a lesser
extent than full-length UL44 (Fig. 1B, compare lanes 13 and 11),
which is consistent with our MS data.
UL44 is a substrate for Cdk1/cyclin B in vitro
Several lines of evidence indicate that UL97 and its homologs
phosphorylate certain proteins on sites that are also phosphorylated
by cdks (Baek et al., 2004; Hamirally et al., 2009; Hume et al., 2008;
Kawaguchi et al., 1999; Kawaguchi and Kato, 2003; Kawaguchi et al.,
2003; Kuny et al., 2010; Prichard et al., 2008; Romaker et al., 2006),
and that cdk activities are required for HCMV replication (Bresnahan
et al., 1997b, 1997a; Feichtinger et al., 2011; Hertel et al., 2007;
Sanchez et al., 2003; Sanchez et al., 2004; Sanchez et al., 2007;
Sanchez and Spector, 2006). In addition, the HSV-1 homolog of UL44,
UL42, has been reported to interact with and be phosphorylated by
cdk1 (Advani et al., 2001, 2003). Thus, we tested whether UL44 can
serve as a substrate of cdk1/cyclinB in vitro.
We incubated recombinant GST-cdk1 (cdk1) and GST-cyclin B
(cycB) with either UL44 or UL44ΔC290 and [32P]-γATP. Lamin A,
which is known to be a substrate of cdk1/cycB (Heald and McKeon,
1990; Peter et al., 1990; Ward and Kirschner, 1990), was used as a
positive control. When lamin A or UL44 were incubated alone, no 32P
incorporationwas observed (Fig. 1B, lanes 2 and 5). However, a robust
signal was observed when these proteins were incubated with cdk1/
cycB (lanes 3 and 6). Addition of an inhibitor of cdk1, CGP74514A,
greatly decreased the level of phosphorylated lamin A and UL44
(lanes 4 and 7). UL44ΔC290 was also phosphorylated by cdk1/cycB
(lane 9) in a CGP74514A-sensitive manner (lane 10), but as observed
with UL97, to a lesser extent than full-length UL44 (Fig. 1B, compare
lanes 6 and 9). In addition, the level of phosphorylation of UL44 or
UL44ΔC290 by cdk1/cycB was comparable with the level of
phosphorylation of these proteins by UL97 (Fig. 1B, compare lanes 6
and 11, and 9 and 14, respectively). Taken together, these data
indicate that UL44 is phosphorylated by cdk1/cycB in vitro.
We then performed a large-scale phosphorylation of UL44 by
cdk1/cycB in vitro. The reaction was resolved by SDS-PAGE and
stained with colloidal blue (Fig. 1C). As with GST-UL97, we observed a
slower migrating form of UL44 after incubation with cdk1/cycB
(Fig. 1C). Both species of phosphorylated UL44 were excised together
and subjected to MS. Coverage of the amino acid sequence of UL44 in
this experiment was approximately 85%. Ten residues were positively
identiﬁed as sites of phosphorylation by cdk1/cyclin B (Table 1,
column 3, listed as conﬁrmed). Both cdkminimal sites (S/T-P) present
in UL44, T45 and T84, were deﬁnitively phosphorylated by
cdk1/cycB. For six phosphopeptides, we were unable to positively
identify phosphorylation sites, yielding a maximum of 14 additional
possible sites of phosphorylation, with ﬁve of these residues iden-
tiﬁed as likely sites of phosphorylation (Table 1, column 3). A
more detailed analysis of the phosphopeptides can be found in
Supplementary Table 2.
Half of the sites that were conﬁrmed to be phosphorylated by cdk1
corresponded to ones positively identiﬁed as being phosphorylated by
UL97 (Table 1, compare columns 2 and 3). When the likely sites of
phosphorylation were included, the overlap in sites phosphorylated
by both enzymes was even more extensive (e.g. T84, S354, S383).
Additionally, there were some UL44 residues that were uniquely
phosphorylated by each kinase in vitro. The residues that we can
identify deﬁnitively as being phosphorylated by one kinase but not
Table 1
Compilation of UL44 phosphorylation residues identiﬁed by MS.
Residue UL97 in vitroa Cdk1/cycB in vitrob HCMV infected cellsc
S8 Conﬁrmed Conﬁrmed Conﬁrmed
T12 Conﬁrmed
T45 Conﬁrmed
S47 Conﬁrmed Possible
T52 Possible
S83 Possible
T84 Possible Conﬁrmed
T164 Conﬁrmed Conﬁrmed
T268 Conﬁrmed
Y282 Possible
S286 Conﬁrmed Conﬁrmed Conﬁrmed
S289 Possible Conﬁrmed
S348 Conﬁrmed
S354 Likely Likely Likely
S355 Conﬁrmed Possible Likely
S367 Likely Likely Conﬁrmed
S368 Possible Possible
T378 Possible Likely
S379 Conﬁrmed Conﬁrmed
Y380 Possible Possible
T382 Possible Possible
S383 Conﬁrmed Likely
S387 Conﬁrmed Conﬁrmed Conﬁrmed
S402 Conﬁrmed Conﬁrmed
S413 Conﬁrmed Possible Likely
S415 Likely Likely
S418 Conﬁrmed Possible Likely
T420 Possible Possible
T427 Conﬁrmed
Residueswere either positively conﬁrmedasaphosphorylation site or thephosphorylation
site could not be identiﬁed among two or more probable sites in a single peptide. In the
latter case, the most likely sites and other possible sites are indicated. See supplementary
information for more detailed analysis.
a Data are compiled from three experiments and two MS facilities.
b Data are compiled from one experiment and one MS facility.
c Data are compiled from two experiments and two MS facilities.
Fig. 1. In vitro phosphorylation of UL44 by UL97 and cdk1/cyclin B. (A) A large-scale phosphorylation reactionwas performedwith UL44 alone (lane 1) or UL44 incubatedwith GST-UL97
(lane 2), and the products were resolved by SDS-PAGE and Coomassie-stained. (B) Radiolabeled phosphorylation reactions were performedwith either cdk1/cyclin B (cycB) or GST-UL97
(UL97) and the substrates lamin A, UL44, or UL44ΔC290 (500 nM), and the products were resolved by SDS-PAGE. Reactionswere assembled as indicated. The kinase inhibitors usedwere
CGP74514A(cdk1 inhibitor) ormaribavir (UL97 inhibitor). Thepositionsof thevarious proteins are indicatedon the rightwith arrows. (C)A large scale phosphorylation reaction assaywas
performedwith UL44 and cdk1/cycB, and the productswere resolved by SDS-PAGE. For all panels, the positions of UL44 and hyperphosphorylated UL44 (UL44-P) are indicated by arrows.
The molecular weights of protein markers are indicated on the left of panels A and C, and the positions of protein kinases and substrates are indicated to the right of panel C.
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(cdk1/cycB) (Table 1, columns 2 and 3). Interestingly, T427 is
predicted to be a consensus site for cdk-mediated phosphorylation,
and phosphorylation of UL44 residue T427 or its substitution with
aspartate has been found to negatively regulate the activity of the
UL44 NLS in transfection assays (Fulcher et al., 2009 and Alvisi et al.,
2011 accompanying article).
Sites of UL44 phosphorylation in infected cells
To identify UL44 phosphorylation sites in infected cells, HFF cells
were either mock-infected or infected with strain AD169rv at anMOI of
3 PFU/cell. Cell lysates were harvested at 72 hpi, when viral DNA
synthesis is robust, and incubated with anti-UL44 antibody. The
resulting immunoprecipitates were resolved by SDS-PAGE and sub-
jected to colloidal blue staining. One of two independent experiments is
shown in Fig. 2A. UL44 was excised and subjected to MS analysis.
Peptide fragments of UL44 of various sizes were identiﬁed with amino
acid sequence coverage of 93% and 83% in the two experiments,
respectively. For six peptides, we positively identiﬁed a single
phosphorylation site (Table 1, column 4; listed as conﬁrmed). We also
recovered phosphopeptides in which phosphorylated residues could
not be identiﬁed deﬁnitively. In these cases, the possible andmost likely
residues are listed (Table 1, column 4). A more detailed analysis of the
UL44 phosphopeptides identiﬁed from AD169rv-infected cells can be
found in Supplementary Table 3.
Taking the positively identiﬁed and most likely sites together, we
found 11 sites of phosphorylation on UL44 from wt HCMV infected
cells. All sites were serine residues, which correlates with Western
blot data using phospho-speciﬁc antibodies (Supplementary Fig. 2).
The locations of these 11 sites within UL44 are depicted in Fig. 2B.
Interestingly, 10 of the 11 sites are located in the C-terminal third
of the protein, which has been shown to be important for viral
replication (Kim and Ahn, 2010; Silva et al., 2010). Importantly, many
of the sites on UL44 that we identiﬁed as being phosphorylated during
infection were also phosphorylated by UL97 or cdk1 in vitro (Table 1).
Fig. 2. Analysis of phosphorylation sites on UL44 from infected cells. (A) HFF cells
(4.5×106) were either mock-infected (lane 1) or infected with AD169rv at an MOI of 3
PFU/cell (lane 2), and immunoprecipitates of UL44 were prepared and resolved by SDS-
PAGE. Proteins were visualized by colloidal blue stain. The position of UL44 is indicated
by an arrow. (B) Cartoon depiction of UL44. The amino acids required, but not
necessarily sufﬁcient for the known biochemical functions of the protein are shown as
indicated. The positions of glycine-rich segments (glycine strings) and the NLS are also
depicted. The locations of eleven residues of UL44 phosphorylated in cells infected with
wild-type HCMV are indicated by a P in a circle with the amino acid denoted.
Fig. 3. PhosphorylationofUL44during infection in thepresenceofUL97andcdk inhibitors.
Mock-infected or HCMV-infected (AD169rv) cells were pulse-labeled for 2 h with [32P]-
orthophosphate in the presence of 1 μM maribavir (MBV), 15 μM roscovitine (ROSCO),
both drugs (M+R) or vehicle (DMSO), and whole cell lysates were prepared at 72 hpi.
(A) UL97 (upper panel), UL44, and β-actin (lower panel) protein levels in lysates were
assessed byWestern blot. Phosphorylated forms of UL97 are indicated (UL97-P). (B) UL44
immunoprecipitationswere prepared from cell lysates, resolved by SDS-PAGE, transferred
to a PVDF membrane and then exposed to a phosphor screen to detect 32P incorporation
(upper panel). The 32P signal was quantiﬁed for each UL44 band and the values for 32P
incorporation into UL44 are shown below the phosphorimage as percent of the DMSO-
treated sample. Themembranewas also subjected toWestern blot analysis to detect UL44
protein levels (lower panel). The signal for UL44was quantiﬁed, and the values are shown
below the Western blot as percent of DMSO-treated sample. (C) Three independent
immunoprecipitations of UL44 from lysates of the same orthophosphate labeling
experiment were performed. The average normalized phosphate incorporation into
UL44 relative to the untreated control is depicted. Error bars are the standard deviation of
the average ratio of the three immunoprecipitations.
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cdk1, in vitro, was also phosphorylated during infection, consistent
with UL97 phosphorylating UL44 during infection.
In one of the two MS analyses of UL44 from infected cells, the
intensities of the peaks of the non-phosphorylated and phosphory-
lated peptides were measured as an estimate of the extent of
phosphorylation at given sites (Supplementary Table 3). The peptide
containing the three sites (S413, S415, and S418) directly upstream of
the NLSwas essentially always phosphorylated on at least one of these
three sites, with a monophosphorylated form estimated to account for
about half of the peptides and more highly phosphorylated forms
the other half. Two phosphopeptides, containing S354/355 and S402,
were estimated to be phosphorylated about half of the time. S8, S286,
and S387 were estimated to be phosphorylated less than 20% of the
time. S348 and S367 were not included in this analysis. Thus, the
major sites of UL44 phosphorylation during infection are likely to be
S413, S415, and S418.
The effects of transient inhibition of UL97 and Cdks on UL44
phosphorylation
To further investigate whether UL44 is phosphorylated by UL97 or
cdks during infection, we performed [32P]-orthophosphate metabolic
labeling experiments of wt infected HFF cells in the presence or absence
ofmaribavir,which speciﬁcally inhibits UL97 (Biron et al., 2002) or a cdk
inhibitor, roscovitine, which inhibits cdks 1, 2, 5, 7 and 9 (Meijer et al.,
1997; Meijer and Raymond, 2003). To limit the activity of cdks that
might substitute for UL97 kinase activity, we performed the experiment
with quiescent HFF cells, produced by serum-starvation. Furthermore,
to ensure that the kinase inhibitors did not affect UL44 gene expressionand to limit secondary effects of these compounds (Bresnahan et al.,
1997a; Krosky et al., 2003a; Sanchez et al., 2004; Sanchez and Spector,
2006), we allowed infections to proceed until 68 hpi before treating
infected cells with 1 μM maribavir, 15 μM roscovitine, both drugs, or
vehicle (DMSO) for 2 h. At 70 hpi, cells were labeled with [32P]-
orthophosphate for 2 h in the presence or absence of kinase inhibitors.
At 72 hpi, cells were harvested and lysed. Levels of UL44, β-actin, and
UL97 in the lysates, as assessedbyWesternblot analysis,werepresent at
similar levels in all infected samples (Fig. 3A).However, inmock-treated
and roscovitine-treated samples, slower migrating forms of UL97,
presumably representing hyperphosphorylated forms of the protein,
were detected (Fig. 3A), while only the fastest migrating form of UL97
Fig. 4. One-dimensional tryptic phosphopeptide analysis of UL44 from infected cells treated
with kinase inhibitors. 32P-labeled UL44 from cells either mock-infected and mock-treated
(DMSO, lane1)or infected (AD169rv) andmock treated(DMSO, lane2), or treatedwith1 μM
maribavir (MBV, lane 3), 15 μM roscovitine (ROSCO, lane 4) or both drugs (M+R, lane 5),
was isolated from themembrane shown in Fig. 3B and extensively digestedwith trypsin. An
unlabeled UL44 immunoprecipitation from an untreated AD169rv infection (Cold IP, lane 6)
as well as UL44 from an in vitro kinase reaction with GST-UL97 (in vitro, lane 7) were also
digestedwith trypsin. The resultingpeptideswere resolvedonanalkaline40%acrylamidegel
and visualized using a phosphorimager. Arrows point to the UL44 phosphopeptides that
were absentwhen UL97 activity was inhibited bymaribavir. A darker exposure of the region
containing these peptides is shown in the lower panel.
272 L.A. Silva et al. / Virology 417 (2011) 268–280wasdetected in samples treatedwithmaribavir (Fig. 3A). These data are
consistent with autophosphorylation, and thus the kinase activity, of
UL97 being effectively inhibited by transient treatment with maribavir.
To evaluate whether UL44 phosphorylation was affected by the
kinase inhibitors, we immunoprecipitated UL44 from each lysate,
resolved immunoprecipitates by SDS-PAGE, transferred the proteins
to a membrane, and measured 32P incorporation into UL44 by autora-
diography (Fig. 3B, upper panel). We also probed the membrane with
anti-UL44 antibody to quantify the amount of UL44 immunoprecipi-
tated from the samples (Fig. 3B, lower panel). We calculated the ratio
of the amount of phosphate incorporation into UL44 to the UL44
protein level for each sample (Fig. 3C). The normalized level of
phosphorylation of UL44 was, if anything, slightly increased (~9%) in
the presence of maribavir and modestly decreased (~16%) in the
presence of roscovitine. Treatment with both drugs resulted in a
reduction in the relative level of phosphorylation that was even
greater (~31%) than the decrease observed with roscovitine alone.
Nevertheless, more than half of the phosphorylation remained after
treatment with both drugs. The remaining phosphorylation of UL44 is
likely due to other cellular kinases (e.g. CK2).
The trends observed in the representative experiment (Figs. 3B
and C) held true for multiple experiments in both quiescent cells and
actively dividing cells (data not shown and Hamirally et al., 2009).
These data indicate that 1) the overall phosphorylation of UL44 can
proceed efﬁciently in the absence of UL97 activity, 2) cdks likely
contribute to the phosphorylation of UL44 in infected cells, and 3)
other cellular kinases are responsible for the large majority of the
phosphorylation of UL44 during infection, at least at 72 hpi. We
suggest that CK2 is one such kinase, given the heavy phosphorylation
of serines adjacent to the UL44 NLS (Supplementary Table 3), and
work implicating CK2 in phosphorylation of this segment (Alvisi et al.,
2005 and Alvisi et al., 2011 accompanying article). In addition, our
results suggest that UL97may bemore important for phosphorylating
UL44 when cdks are inhibited (see Discussion).
Transient inhibition by maribavir affects two UL44 phosphopeptides
We wished to investigate the possibility that, although overall
phosphorylation of UL44 can proceed in the absence of UL97 activity
in infected cells, this kinase might be responsible for phosphorylation
of speciﬁc sites on UL44. Towards that end, the phosphorylated
samples shown in Fig. 3B, as well as a sample of UL44 from an in vitro
phosphorylation reaction with GST-UL97, were excised from the
membrane and extensively digested with trypsin. The resulting
peptides were resolved on an alkaline 40% polyacrylamide gel and
visualized by autoradiography. Multiple tryptic phosphopeptide
species of UL44 were observed following digestion of UL44 from
mock-treated cells (Fig. 4, lane 2), as well as with samples from
extracts of cells treated with maribavir, roscovitine or both drugs
(Fig. 4, lanes 3, 4, and 5, respectively). As indicated by the arrows on
the left of Fig. 4, a substantial reduction in the signal of two particular
peptides was evident in samples that had been treated with
maribavir, either alone (lane 3) or in the presence of roscovitine
(lane 5), as compared to the mock-treated control (lane 2). The
reduction in labeling of these two peptides was speciﬁc, as maribavir
did not reduce the labeling of other peptides (Fig. 4). The two peptides
and the reduction in labeling are more evident in a darker exposure of
this region of the gel (Fig. 4, lower panel). Notably, these phospho-
peptides migrated with the same mobility as phosphopeptides of
UL44 from an in vitro phosphorylation reaction with UL97 (lane 7).
Although we did not observe any major decrease in any speciﬁc
phosphopeptide in samples treated with roscovitine, the phosphor-
ylation of the majority of the peptides decreased (lanes 4 and 5).
Similar results were observed in another independent experiment.
Several attempts were made to identify the two peptides whose
phosphorylation was diminished with maribavir treatment using MS;however, these efforts failed likely due to the low abundance of the
peptides in the sample. Regardless, these results provide further
evidence that UL44 is directly phosphorylated by UL97 during
infection, albeit to a limited extent. The results also make it highly
unlikely that UL97 is responsible for the heavy phosphorylation of the
serines adjacent to the UL44 NLS.
Construction and characterization of UL44 phosphorylation mutants
To determine whether particular UL44 phosphorylation sites are
important for viral replication, we used site-directed mutagenesis to
construct HCMV mutants that express UL44 that cannot be phos-
phorylated at certain sites (Phos mutants). For our initial set of
mutants, eight of the eleven serine residues (all but those adjacent to
the NLS) positively or most likely identiﬁed as sites of phosphoryla-
tion during infection were substituted with alanine in four different
groupings (Table 2): Phos-1 contained a single alanine substitution at
the only N-terminal site (serine 8); Phos-2 contained seven alanine
substitutions at sites located in the C-terminus of the protein (serines
286, 348, 354/355, 367, 387 and 402); Phos-3 contained seven alanine
substitutions at sites that were found to be phosphorylated during
Table 2
Alanine substitutions of phosphorylation sites in UL44 Phos mutants.
Mutation Phos-1 Phos-2 Phos-3 Phos-1/2 Phos-4
S8A + + +
S286A + + +
S348A + +
S354A + + +
S355A + + +
S367A + + +
S387A + + +
S402A + + +
S413A +
S415A +
S418A +
Fig. 5. Relative phosphorylation levels of UL44 Phos mutants. HFF cells were either
mock-infected or infected with parental (AD169rv) or Phos mutant viruses at an MOI of
1 PFU/cell and pulse-labeled for 2 h with [32P]-orthophosphate at 70 hpi. UL44
immunoprecipitations were prepared from cell lysates harvested at 72 hpi, resolved by
SDS-PAGE, transferred to a PVDF membrane. The normalized level of phosphorylation
of UL44 from each virus was calculated as the ratio of phosphate incorporation
(relative to the AD169rv control) to protein level (relative to the AD169rv control) as
described for Fig. 3. The phosphorimage and Western blot of the membrane are shown
in Supplementary Fig. 3.
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387, and 402); Phos-1/2 contained alanine substitutions at eight sites
and is a combination of Phos-1 and Phos-2 mutants (serines 8, 286,
348, 354/355, 367, 387 and 402). These four Phos mutants were
constructed as BACs as described in Materials and methods and
veriﬁed by sequencing. Each mutant BAC yielded infectious virus
when electroporated into HFF cells, which indicates that phosphor-
ylation of UL44 of these residues is not essential for viral replication.
Additionally, Western blot experiments indicated that the mutations
did not meaningfully alter the accumulation of UL44 (data not
shown).
To investigate whether the alanine substitutions in UL44 affected
phosphorylation, we performed [32P]-orthophosphate metabolic
labeling. In this experiment, dividing HFF cells were infected with
strain AD169rv or each mutant virus (MOI=1 PFU/cell), labeled with
[32P]-orthophosphate at 70 hpi for 2 h, and whole cell lysates were
harvested at 72 hpi. UL44 was immunoprecipitated from cell lysates,
resolved by SDS-PAGE and transferred to a membrane. Phosphate
incorporation into UL44 expressed from each virus was assessed by
autoradiography and quantiﬁed (Supplementary Fig. 3). The PVDF
membrane was also probed with anti-UL44 antibody to determine
UL44 levels (Supplementary Fig. 3). We calculated the ratio of
phosphate incorporation into UL44 to UL44 levels to obtain the
normalized level of UL44 phosphorylation for each mutant virus as
compared to AD169rv (Fig. 5, WT). We observed at most a slight
decrease in the normalized level of UL44 phosphorylation from Phos-
1, which contains only 1 alanine substitution. We observed larger
decreases (~40%) in the levels of relative phosphorylation for the Phos
mutants that contained 7 or 8 alanine substitutions (Phos-2, Phos-3
and Phos-1/2). Thus, substitutions at these sites lead to a decrease in
the level of UL44 phosphorylation, as expected. However, these data
indicate that a substantial amount of relative phosphorylation occurs
at other possible sites of phosphorylation, most likely S413, S415, and
S418.
Replication and DNA synthesis of viable UL44 Phos mutants
To test whether phosphorylation of UL44 at these sites affects viral
replication, dividing HFF cells were infected with strain AD169rv or
Phos mutants at an MOI of 1 PFU/cell. Virus produced from infected
cultures was harvested every 24 h for 6 days following infection and
titrated (Fig. 6A). Replication of the four Phos mutants was slightly
delayed compared to the parental virus, AD169rv in each of three
independent experiments (averages presented in Fig. 6A). At days 3
and 4 pi, we observed a modest decrease (5- to 10-fold) in viral titers
of the mutant viruses compared to AD169rv. These decreases became
even less apparent (b5-fold) at days 5 and 6 pi (Fig. 6A). Nevertheless,
the decrease in viral titers of all the Phos mutants was statistically
signiﬁcant on days 4 and 5 (Pb0.001 as determined by 2-way ANOVA
followed by Bonferroni's post-test; Fig. 6A, two asterisks), and the
decrease in viral titers for Phos-1, Phos-2 and Phos-3 was statisticallysigniﬁcant on day 6 as compared to the parental virus' titers
(Pb0.001; Fig. 8A, one asterisk). We also assessed viral titers of the
Phos mutants at 3 dpi in non-dividing cells, when mutant titers were
lowest as compared to parental virus in dividing cells. HFF cells were
serum-starved for 3 days and then infected with wt or mutant viruses
(MOI=1 PFU/cell). The titers of progeny virus from the four Phos
mutants at 3 dpi were again rather modest (within 3-fold of wt
levels), but the slight decrease in titers was statistically signiﬁcant
(Pb0.01) (Supplementary Fig. 4).
We also evaluated kinetics of viral DNA synthesis of the Phos
mutants using quantitative real-time PCR, measuring copies of the
UL83 gene normalized to copies of the cellular β-actin gene. With the
parental virus, levels of viral DNA increased each day until day 4 pi
when the levels of viral DNA began to plateau (Fig. 6B). The four UL44
phosphorylationmutants replicated their DNAwith similar kinetics as
the parental virus (Fig. 6B). Levels of viral DNA from cells infected
with mutant viruses were within 3-fold of levels of the parental virus
at each dpi, and these differences in DNA accumulation were not
statistically signiﬁcant (PN0.05 as determined by 2-way ANOVA
followed by Bonferroni's post-test). We obtained similar results in
non-dividing, serum-starved cells (data not shown). The data indicate
that these Phos mutants exhibit a modest defect in viral replication,
and little or no defect in viral DNA synthesis.Substitution of serines at positions 413, 415 and 418 in UL44 is lethal to
HCMV
In our MS analysis, the segment of UL44 containing residues S413,
S415 and S418 was the most highly phosphorylated in infected cells
(Supplementary Table 3). In addition, these serines have both been
predicted and found to be substrates for protein kinases CK1 and CK2
(Alvisi et al., 2005 and Alvisi et al., 2011 accompanying article). To
investigate the requirement for these serines in viral replication, the
three codons for these residues were mutated to codons encoding
alanine in the AD169rv BAC to create Phos-4 (Table 2). This BAC or the
AD169rv BAC was electroporated into HFF cells. Complete cytopathic
effectwasobserved in cell cultures electroporatedwith theparental BAC
and infectious virus was readily detected (Fig. 7A). However, at no time
could any cytopathic effect be observed in cells electroporated with
Phos-4, and no infectious viruswas detected (Fig. 7A). To ensure that no
Fig. 6. Viral replication kinetics and viral DNA synthesis kinetics of Phos mutant viruses.
(A) HFF cells were infected with parental (AD169rv), Phos-1, Phos-2, Phos-3 or Phos-1/2
mutant viruses at anMOI of 1 PFU/cell. Supernatant was harvested at the times indicated.
Virus yieldsweredeterminedbyplaqueassays. Error bars represent the standarddeviation
fromtheaverage titers of three independent experiments. Errorbars shorter than thepoint
symbols were omitted. *Pb0.001 as determined by two-way ANOVA followed by
Bonferroni multiple comparison post-tests. One asterisk indicates that Phos-1, Phos-2
and Phos-3 exhibited a statistically signiﬁcant decrease in viral titers. Two asterisks
indicate that all Phosmutants exhibited a statistically signiﬁcantdecrease inviral titers. (B)
HFF cells were infected with AD169rv (WT), Phos-1, Phos-2, Phos-3 or Phos-1/2 mutant
viruses at anMOI of 1 PFU/cell. Total DNAwas harvested at the times indicated. Viral DNA
accumulation was assayed by real-time PCR measuring the copies of the UL83 gene
normalized to copies of the cellular β-actin gene. Error bars represent the standard
deviation from the average of three independent experiments, except in the case of Phos-1
and Phos1/2 at day 5 when only duplicates are present and standard deviations were not
calculated. Error bars shorter than the point symbolswere omitted. PN0.05 for all samples
on all days as determined by two-way ANOVA followed by Bonferroni multiple
comparison post-tests.
Fig. 7. Mutation of serines at positions 413, 415 and 418 in UL44 yields a replication-
defective BAC. (A) AD169rv and Phos 4 BACs were electroporated into HFF cells. The
amount of virus in each transfected cell culture supernatant was determined by
titration of cell culture supernatant on HFF cells. Data shown are representative of two
independent experiments. (B) The mutations in the Phos 4 BAC were rescued to restore
wt sequence to create BAC-Phos-4rev. Virus reconstituted from electroporation of
Phos4rev or AD169rv BACs were used to infect HFF cells at a MOI of 1 PFU/cell. The
amount of virus produced from each infection 5 dpi was determined by titration of virus
on HFF cells. Data shown represent the mean value and standard deviation of results
obtained from three independent experiments.
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mutated segment of the BACwas replacedwith thewt sequence so that
the alanine residues at positions 413, 415 and 418 were reverted to
serine residues in Phos-4 to create Phos-4rev. Complete cytopathic
effect could be observed in HFF cells transfected with this BAC. Peak
titers of the reconstituted virus were comparable to those of AD169rv
(Fig. 7B). These data indicate that one or more of these three serines
located upstream of the NLS of UL44 is critical for viral replication.
Subcellular localization of UL44 expressed from Phos-4
In transfection studies, serines 413 and 418 were found to be
important for enhanced nuclear import of UL44 and binding to importin
α/β (Alvisi et al., 2005 and Alvisi et al., 2011 accompanying article). To
investigate the subcellular localization of the triply substituted UL44 in
infected cells, the AD169rv and Phos-4 BACs were electroporated into
HFF cells and immunoﬂuorescence assays were performed using a
monoclonal antibody recognizing UL44 (Fig. 8). Cells were also stained
with Hoechst reagent to visualize the nucleus. UL44 could be visualized
in a distinct structure within the nucleus in cells electroporated with
parental BAC (Fig. 8, panels A–C). This structure is most likely adeveloping replication compartment (Ahn et al., 1999; Penfold and
Mocarski, 1997). In cells electroporated with Phos-4, very little UL44
could be found in the nucleus. Rather, diffuse staining was observed
throughout the cytoplasm(Fig. 8, panelsD–F). Thus, consistentwith and
extending the work of Alvisi et al. in transfected cells (Alvisi et al., 2005
and Alvisi et al., 2011 accompanying article), the triple substitution
makes nuclear entry of UL44 highly inefﬁcient in infected cells, which
suggests that the inability of Phos-4 to produce infectious virus is due to
inefﬁcient nuclear accumulation of UL44.
Discussion
UL44 has long been described as a phosphoprotein (Gibson et al.,
1981). Indeed, the accessory subunits of herpesvirus DNA polymerases
are typically phosphorylated during infection (Chan and Chandran,
2000; ChangandBalachandran, 1991;Gibsonet al., 1981;Marsdenet al.,
1987; Roeckel and Mueller-Lantzsch, 1985), but for many of these
proteins, including UL44, the sites of phosphorylation and the
signiﬁcance of these modiﬁcations during infection had not been
determined. For UL44,wewere particularly interested in addressing the
hypotheses that i) UL97 phosphorylates UL44 in infected cells (Krosky
et al., 2003b), and ii) UL97-mediated phosphorylation of UL44 is
important for viral DNA synthesis and is thus the mechanism by which
pharmacological or genetic inhibition of UL97 kinase activity affects
viral DNA replication (Jacob et al., 2011; Krosky et al., 2003b; Marschall
et al., 2003;Mercorelli et al., 2008;Michel andMertens, 2004;Wolf et al.,
2001). In this study, we identiﬁed the sites on UL44 that are
phosphorylated by UL97 and also by cdk1/cyclin B in vitro, as well as
Fig. 8. Subcellular localization of UL44. HFF cells electroporated with either AD169rv-BAC or BAC-Phos-4 were seeded 72 h after electroporation and stained with MAb recognizing
UL44, secondary antibody conjugated to Alexa 488 and Hoechst reagent. Cells electroporated with AD169rv-BAC are shown in panels A–C, and cells electroporated with BAC-Phos-4
are shown in panels D–F. Panels a and d in the left column show Hoechst staining and panels b and e in the middle column show the localization of UL44. Panels c and f in the right
column show the merged images from the left and middle columns. Magniﬁcation: 63×.
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tested the effects of transient inhibition of UL97 and cdks on UL44
phosphorylation in infected cells. The coincidence of sites phosphory-
lated by UL97 in vitro and from infected cells, and our ﬁnding that
maribavir inhibits phosphorylation of speciﬁc peptides of UL44 in
infected cells adds to the evidence that UL44 is a substrate of UL97
during infection. However, theUL97 inhibitor, maribavir, did not reduce
the overall incorporation of phosphate into UL44, and affected only two
weakly labeled phosphopeptides. Thus, UL97 does not appear to be a
major contributor to UL44 phosphorylation during HCMV infection, at
least at 72 hpi. Additionally, substitutions of most of the sites
phosphorylatedbyUL97 in vitro that are alsophosphorylated in infected
cells had only a modest effect on viral replication and little or no effect
on DNA synthesis. In contrast, substitution of Ser 413, 415, and 418,
which our analysis identiﬁed as the most extensively phosphorylated
residues of UL44 (and thus highly unlikely to bemainly phosphorylated
by UL97), resulted in failure of a mutant BAC to replicate. We discuss
these results in terms of phosphorylation of UL44 by UL97, by cellular
kinases, and the role of UL44 phosphorylation in viral replication.
UL44 phosphorylation by UL97
As noted above, collectively our data add to previous evidence
(Krosky et al., 2003) that UL44 is a substrate of UL97 during infection.
Our analyses did not permit us to deﬁnitively identify the sites that are
phosphorylated by UL97 during infection. Nevertheless, S402 is a
likely candidate for such a site, as this residue was phosphorylated by
UL97, but not cdk1, in vitro, and is phosphorylated during infection.
However, S413, S415 or S418 are not likely candidates, since peptides
containing these three sites were found to be phosphorylated 100% of
the time, and the phosphopeptides affected by maribavir treatment
were only modestly labeled by 32P. Additionally, MS analysis of cells
infected with a UL97 null mutant virus readily detected phosphory-
lation at these sites (data not shown). Results from MS analyses
comparing UL44 phosphorylation in cells infected with WT and the
UL97 null mutant were too inconsistent to be able to interpret a failure
to detect phosphorylation at a given site (data not shown).
Intriguingly, 32P labeling of UL44 was slightly elevated in infected
cells transiently treated with maribavir. This observation may relate
to a previous observation: when maribavir was present throughout
viral infection, only the most acidic species, and therefore likely the
most phosphorylated forms, of UL44 were detected (Krosky et al.,
2003). On the other hand, when we transiently treated cells withmaribavir and roscovitine, 32P incorporation into UL44 was lower
than when roscovitine was used alone. Therefore, the kinase activity
of UL97 may be more important for UL44 phosphorylation when the
activities of cdks are reduced or absent.
UL44 phosphorylation by cellular kinases
Our previous results (Krosky et al., 2003b) and our phospholabel-
ing inhibition and phosphotryptic peptide analyses of UL44 indicate
that UL44 is largely phosphorylated by kinases other than UL97
during infection. We think it likely that these kinases include cdks.
Several candidate sites that were phosphorylated by cdk1 in vitro
were also phosphorylated in infected cells. Additionally, transient
treatment of infected cells with roscovitine, an inhibitor of multiple
cdks, including cdk1 (Meijer et al., 1997; Meijer and Raymond, 2003),
inhibited phosphate incorporation into UL44 and decreased labeling
of most phosphopeptides. It also seems likely that cellular kinases CK2
and possibly CK1 phosphorylate UL44 during infection (see below),
and other kinases may also be involved.
Role of UL44 phosphorylation in viral replication
It has been widely proposed that inhibition of UL97-mediated
phosphorylation of UL44 is the mechanism by whichmaribavir affects
viral DNA replication and viral yield (Jacob et al., 2011; Krosky et al.,
2003b; Marschall et al., 2003; Mercorelli et al., 2008; Michel and
Mertens, 2004; Wolf et al., 2001). However, substitutions of sites
within UL44 that were found to be phosphorylated in infected cells,
including ones phosphorylated by UL97 in vitro other than those
adjacent to the NLS (which are highly unlikely to be phosphorylated
by UL97 in infected cells), had little effect on viral DNA synthesis, and
only modestly affected virus production. Thus, these results suggest
that UL97-mediated phosphorylation of UL44 is not the principal
mechanism bywhich UL97—and thusmaribavir—inﬂuences viral DNA
synthesis and virus production. Recent work from our lab suggests
that UL97 likely modulates viral DNA synthesis through a mechanism
involving phosphorylation of retinoblastoma protein family members
in quiescent cells (Kamil et al., 2009). Nevertheless, the modest
defects in viral replication kinetics of the viable Phosmutants raise the
possibility that UL97 phosphorylation may impact UL44 function
during infection. If so, these phosphorylation sites might affect a
function of UL44 other than DNA synthesis—perhaps, transcription of
late genes (Isomura et al., 2007; Isomura et al., 2008).
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of the C terminal NLS (Alvisi et al., 2005 and Alvisi et al., 2011
accompanying article). Substitution of S413 or S418 with alanine
results in decreased UL44 NLS function in transient transfection
assays (Alvisi et al., 2005 and Alvisi et al., 2011 accompanying article).
Our data expand upon these ﬁndings, as substitution of serines 413,
415 and 418 in the context of the viral genome (the Phos-4 mutant),
resulted in a loss of nuclear localization of UL44, and a virus that was
unable to replicate. Although it has not yet been demonstrated that
CK2 and CK1 phosphorylate these sites within UL44 during HCMV
infection, a simple interpretation of our data together with those of
Alvisi et al. (Alvisi et al., 2005 and Alvisi et al., 2011 accompanying
article) is that phosphorylation of the three serines upstream of the
NLS by these protein kinases is required for UL44 nuclear localization
in infected cells, and thus HCMV replication. Notably, almost all of the
phosphorylation sites of UL44 we identiﬁed during infection were
located in the C-terminus of the protein. We and others have recently
established that during HCMV infection the C-terminal segment of
UL44 is required for viral replication (Kim and Ahn, 2010; Silva et al.,
2010). Speciﬁcally, we found that this segment is crucial both for
nuclear localization and at least one other function that is important
for the proper formation of viral DNA replication compartments
(Silva et al., 2010). In the present study, our results with the Phos4
mutant reinforce the importance of this segment for nuclear
localization, and stand in contrast to a report to the contrary (Kim
and Ahn, 2010; Silva et al., 2010). In addition, UL44 has been reported
to interact with a number of viral and cellular proteins (Fulcher et al.,
2009; Gao et al., 2008; Strang et al., 2009; Strang et al., 2010a, 2010b).
It is possible that phosphorylation of UL44 can modulate binding to
these, or other undiscovered, binding partners. Indeed phosphoryla-
tion at T427 can modulate binding to the cellular protein BRAP2
(Fulcher et al., 2009).
We caution that we limited our studies of UL44 phosphorylation in
infected human foreskin ﬁbroblasts at 72 hpi. UL44 appears to be
phosphorylated throughout infection (Gibson, 1984). It is possible
that the sites of phosphorylation on UL44, their prevalence, and the
viral and cellular kinases that phosphorylate these sites, change as
infection proceeds, as has been observed with the Epstein–Barr virus
(EBV) homolog BMRF1 (Ohashi et al., 2007; Wang et al., 2005), or
with different cell culture conditions (Chou et al., 2006). Thus, UL44
phosphorylation appears to be complex and there is clearly more to
learn about the role of this important modiﬁcation of UL44 during
HCMV infection.
Materials and methods
Plasmids, BACs, and primers
The AD169rv bacterial artiﬁcial chromosome (BAC) clone of HCMV
wild-type (wt) strain AD169varATCC (Borst et al., 1999; Hobom et al.,
2000) was generously provided by Ulrich H. Koszinowski (Ludwig-
Maximilians University). The pp71 expression plasmid, pCGN71
(Baldick et al., 1997), was kindly provided by Thomas Shenk (Princeton
University). The Cre-expression plasmid, pBRep-Cre (Hobom et al.,
2000), was kindly provided byWolfram Brune (Robert Koch Institute).
pEPkan-S was kindly provided by Nikolaus Osterrieder (Cornell
University). The E. coli strain GS1783 used for mutagenesis of the wt
AD169 BAC was a generous gift from Greg Smith (Northwestern
University). pAB1-bactinPCRscript was kindly provided by Robert
Kalejta (University of Wisconsin-Madison). The sequences of primers
used to construct mutants are provided in Supplemental Table 4.
Expression and puriﬁcation of proteins
Full-length UL44, cleaved from recombinant GST-UL44, was
puriﬁed from Escherichia coli harboring the pD15-UL44 plasmid aspreviously described (Loregian et al., 2004a), with the addition of
passing a high salt wash containing 1 M NaCl over the glutathione-
Sepharose 4FastFlow column to remove a contaminating kinase. The
preparation contained N95% full-length UL44 and small amounts of
uncleaved fusion protein and degradation products of UL44 (Supple-
mentary Fig. 1A). UL44ΔC290 was kindly provided by Jennifer Baltz
and puriﬁed as previously described (Appleton et al., 2004). GST-UL97
was puriﬁed as previously described (He et al., 1997). His-Lamin A
was puriﬁed as previously described (Hamirally et al., 2009).
Quantitative amino acid analysis (performed by theMolecular Biology
Core Facility, Dana-Farber Cancer Institute) was used to determine the
concentration of proteins puriﬁed by our lab. Cdk1/cyclin B was
purchased from Cell Signaling Technology.In vitro kinase reactions
Phosphorylation of UL44 by GST-UL97 in vitro kinase reactions was
carried out using optimized kinase buffer containing 10 mMHEPES [pH
8.0], 25 mMNaCl, 10 mMMgCl2, 2 mMDTT, and 200 μMunlabeled ATP
(kinase buffer). To measure phosphorylation, 0.125 μL 32P-γATP
(6000 Ci/mmol) was included in a 20 μL reaction. Reactions were
conducted with the concentrations of protein indicated in the ﬁgure
legend. In reactions where kinase inhibitors were included, 1 μM
maribavir (a generous gift from John Drach and Karen Biron) or 500 nM
CGP74514A (Calbiochem) was added. The reaction mixtures were
incubated at 37 °C for 60 min and the reactions were terminated by the
addition of 5× SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
sample buffer. The samples were heated at 100 °C for 5 min and
separated by 8% SDS-PAGE. Gels were dried onto blotting paper under
vacuum and incorporated 32P label was assessed with a PhosphorIma-
ger (Molecular-Imager FX System; Bio-Rad).
To prepare UL97 phosphorylated UL44 for MS analysis, ~2.5 μg of
puriﬁed UL44 was incubated with ~125 ng of GST-UL97 in kinase
buffer lacking NaCl, making the effective salt concentration 86 mM. A
negative control reaction included 1 μM maribavir to inhibit GST-
UL97 kinase activity. For a large-scale preparation of cdk1 phosphor-
ylated UL44, ~2.5 μg of UL44 was incubated with ~125 ng GST-cdk1/
GST-cyclinB in kinase buffer lacking NaCl, making the effective salt
concentration 123 mM. Reactions were incubated for 1.5 h at 37 °C
and then resolved by 8% SDS-PAGE. Proteins were visualized with
Coomassie blue or colloidal blue. UL44 was excised from the gels and
submitted for MS analysis.MS analysis
Phosphorylated UL44 samples were submitted to the Taplin MS
Facility, Harvard Medical School. In some experiments, samples were
also submitted to the MS Core Facility at Beth Israel Deaconess
Hospital. At both facilities UL44 was analyzed for the identiﬁcation of
phosphorylation sites by LC/tandem MS. The relative amounts of
phosphorylated and unphosphorylated peptides were estimated
in one experiment by the Taplin Facility by measuring the peak
intensities of the relevant peptides.Cells and viruses
Primaryhuman foreskinﬁbroblast (HFF) cells, isolateHs27 (American
Type Tissue Culture Collection), were used to support HCMV replication
and were cultured in Dulbecco's modiﬁed Eagle's medium (DMEM)
(CellGro) supplemented with 10% fetal bovine serum (FBS, Sigma),
200 U penicillin and 200 U streptomycin per mL (Gibco; Carlsbad, CA)
(DMEM-10%) at 37 °C in 5%CO2. Viruses usedwereHCMVAD169rv, and
mutants derived from it, which are described below. HCMV stocks were
titrated using plaque assays.
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Western blot analyses of UL97 and β-actin were performed as
previously described (Hamirally et al., 2009). Western blot analysis of
UL44 was performed using anti-UL44 primary antibody (αICP36,
Virusys, Sykesville, MD) diluted 1:8000.
Immunoprecipitations from infected cells
HFF cells (4.5×106) were either mock-infected or infected with
AD169rv, at an MOI of ~3 PFU/cell and cell lysates were harvested at
72 hpi in EBC2 buffer (50 mM Tris–HCl [pH 8.0], 300 mM NaCl, 2 mM
EDTA, 0.5% NP-40) supplemented with protease and phosphatase
inhibitors. Immunoprecipitations of UL44 were carried out as
previously described (Strang et al., 2009) and visualized by colloidal
blue staining. UL44 was excised from the gels and submitted for MS
analysis as described above.
Orthophosphate labeling
HFF cells (1.75×105) were seeded into 12-well plates in DMEM
supplemented with 2% FBS. Twenty-four hours post seeding, the 2%
mediumwas removed, the monolayers were washed and replenished
with DMEM containing 0.1% FBS. Infections, drug treatment (68 hpi)
and radiolabeling (70 hpi) were carried out in DMEM containing 0.1%
FBS as previously described (Hamirally et al., 2009). At 72 hpi, cells
lysates were lysed in 500 μL of EBC2 buffer supplemented with
protease and phosphatase inhibitors. UL44 was immunoprecipitated
as previously described (Strang et al., 2009), resolved by 8% SDS-
PAGE, transferred to PVDF membrane and exposed to a Phosphor-
imager. The PVDF membrane was then analyzed by Western blotting
for UL44 as described above. Experiments were initially performed
using a series of three-fold dilutions of protein to ensure that
quantiﬁcation of UL44 protein levels was accurate. In multiple
experiments, using multiple methods of detection, the quantiﬁed
levels of UL44 protein accurately reﬂected the three-fold dilution
series. For the experiments shown, we loaded the entire sample into
one well of the SDS-PAGE gel. Quantiﬁcations of the phosphorimage
and Western blot were performed using Quantity One software. We
then calculated the ratio of the relative level of 32P label in each
sample by dividing the amount of phosphate incorporation into UL44
by the UL44 protein level for each sample.
One-dimensional analysis of tryptic peptides
Immunoprecipitated UL44 from 32P-radiolabeled, infected cells,
either untreated or treated with kinase inhibitors as described above,
as well as UL44 radiolabeled using GST-UL97 in vitro (as described
above) and unlabeled UL44 immunoprecipitated from infected cells,
were excised from the PVDFmembrane and digested in-membrane as
described (Meisenhelder, 1999) in 50 μl digestion buffer (50 mM
Tris–HCl [pH 8.0], 1% TX-100, 10% acetonitrile) containing 2.5 μg
sequencing grade modiﬁed trypsin (Promega). Phospholabeled
peptides of UL44 were resuspended in 25 μl of sample buffer
(125 mM Tris–HCl and 6 M urea) and separated on an alkaline 40%
acrylamide gel as previously described (West et al., 1984). The gel was
dried, exposed to a PhosphorImager screen for ~5 weeks and was
visualized by PhosphorImager analysis.
BAC mutagenesis and reconstitution of virus
To construct a shuttle plasmid for mutagenesis of the UL44 gene,
UL44 and ﬂanking sequences were ampliﬁed by PCR from the
AD169rv BAC DNA using primers upstream and downstream of the
UL44 ORF. The resulting PCR product was subcloned into pCR2.1-Topo
vector (Invitrogen), resulting in plasmid TOPO-UL44ﬂanks. The KpnI–PstI restriction fragment of TOPO-UL44ﬂanks was then inserted into
pUC19, resulting in plasmid pUC19-44. The I-SceI–AphAI cassette
containing a kanamycin resistance gene with a 5′ I-Sce I site was
ampliﬁed by PCR from plasmid pEPkan-S (Tischer et al., 2006) using
primers containing overlapping UL44 sequences and a unique BglII
site. BglII-digested PCR product was ligated into pUC19-44, resulting
in plasmid pUC19-44kan. Site directed mutagenesis using the
QuikChange method (Stratagene; La Jolla, CA) was performed on
pUC19-44kan to introduce S8A, S286A, S348A, S354A/S355A, S367A,
S387A and S402A substitutions in different combinations and yielded
plasmids pUC19-Phos-1, -2, -3 and -1/2. Restriction enzyme analysis
and DNA sequencing conﬁrmed the presence of each mutation and
the absence of spurious mutations.
Mutagenesis of the HCMV BAC AD169rv was performed accord-
ing to the protocol outlined in Tischer et al. (2006) as previously
described (Strang et al., 2010a). Brieﬂy, we constructed a bacmid,
ΔUL44-Zeo, containing the majority of the UL44 ORF replaced by the
Zeocin resistance cassette, which was PCR ampliﬁed from pZeo
(Invitrogen) by using partially overlapping primers containing UL44
sequences, utilizing the two-step Red recombination method
(Tischer et al., 2006). PCR products containing mutant UL44 ORFs
were used for two-step Red recombination of ΔUL44-Zeo as
described (Tischer et al., 2006) to generate BAC-Phos-1, -2, -3, and
-1/2. For generation of BAC-Phos-4 containing alanine substitutions
in UL44 at residues 413, 415 and 418, mutagenic PCR primers were
used to amplify a DNA sequence from plasmid pEPkan-S (Tischer et
al., 2006). Red recombination was used to introduce the PCR product
into the AD169rv BAC as described (Strang et al., 2010a; Tischer et
al., 2006) to generate BAC-Phos-4. The resulting mutant BACs were
sequenced to conﬁrm the presence of mutations in the UL44 coding
sequence. To generate the rescued version of BAC-Phos-4, bacteria
harboring the mutant BAC were transformed with a PCR product
ampliﬁed using primers containing wt UL44 sequences. The PCR
product was introduced into the mutant BAC as before using Red
recombination (Tischer et al., 2006). Supplementary Table 4 lists all
the primers used in this study.
To generate viruses, AD169rv BAC and the various mutant BACS
were electroporated into HFF cells as described previously (Tischer
et al., 2006), with plasmids pCGN71 (Baldick et al., 1997), expressing
the viral transcriptional transactivator pp71, and pBRep-Cre (Hobom
et al., 2000). Cells were maintained until ~90% cytopathic effect (CPE)
was observed, at which time the supernatants of these cultures were
collected as viral stocks, stored at −80 °C, and titrated using plaque
assays.
Viral replication kinetics
HFF cells (7.5×104 per well) were seeded in 24-well plates.
Twenty-four hours later, cells were infected with AD169rv or mutant
viruses at an MOI of 1 PFU/cell (veriﬁed by back titration).
Supernatants were harvested at 24 h intervals until 6 days post
infection and stored at −80 °C until titration. Viral titers were
determined by plaque assays. Data are presented as the average viral
titer±standard deviation obtained from three independent experi-
ments. Statistical analysis was performed with GraphPad Prism
software using two-way ANOVA to determine the statistical signiﬁ-
cance of differences between the average viral titers of the different
viruses in dividing cells followed by Bonferroni's Multiple Comparison
Post-Test to determine statistical signiﬁcance of differences between
the average viral titers on each day as compared to wt titers. Statistical
signiﬁcance was accepted at Pb0.05.
Viral DNA accumulation analysis by quantitative PCR
HFF cells (7.5×104) were seeded in 24-well plates and 24 h later
were infected with AD169rv or mutant viruses at a target MOI of 1 PFU/
278 L.A. Silva et al. / Virology 417 (2011) 268–280cell (veriﬁed by back titration). Total DNA was harvested in lysis buffer
(10 mM Tris [pH 7.5], 10 mM EDTA, 0.5% SDS, 100 mMNaCl) at various
times after infection and stored at−80 °C. Total DNAwas then puriﬁed
using the DNeasy Blood and Tissue kit (Qiagen) per the manufacturer's
instruction. Real-time quantitative PCR was used to determine the
number of viral copies in the total DNA samples from infected cells as
previously described (Saffert and Kalejta, 2007; Strang et al., 2010a),
using primer and probe sets for UL83 (Gault et al., 2001) and β-actin
(Hanﬂer et al., 2003). PCR reactions contained 4 μl of 150 μl of extracted
DNA, 900 nMof each primer, 250 nMprobe, 6 μl TaqManUniversal PCR
Master Mix without AmpErase UNG (Applied Biosystems Inc.) and
nuclease-free water to 12 μl. Real-time quantitative PCR was run on an
ABI 7900HTanddatawere analyzedusing the SDS 2.3program(Applied
Biosystems Inc.). Data are presented as the average ratio of UL83 copies
to β-actin copies and when applicable, ± the standard deviation
obtained from three independent experiments.
Immunoﬂuorescence
HFF cells were electroporated with either BAC-AD169rv or BAC-
Phos-4 as previously described (Tischer et al., 2006). Seventy-two
hours later, 5×104 HFF cells were plated onto glass coverslips. Cells
were ﬁxed and stained 24 hours later using anti-UL44 antibody
(Virusys) and Hoechst reagent (5 mg/mL) as previously described
(Strang et al., 2010a). Cells were imaged on an Axioplan 2 microscope
(Zeiss) with a 63×objective and Hamamatsu CCD camera (model
C4742-95). Images were deconvolved using the inverse ﬁlter
algorithm in the Axiovision (Rel.4.5) software.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.virol.2011.06.008.
Acknowledgments
This work was supported by grants from the National Institutes of
Health to D.M.C. (RO1 AI019838 and RO1 AI26077) and J.P.K (F32
AI075766), from the William Randolph Hearst Foundation to B.L.S.,
and from theHarvard Institute to Global Health to E.W.L., for whichwe
are grateful. We thank all members of the Coen and Hogle labs for
helpful discussions and technical advice, with special thanks to
Jennifer Baltz, Martha Kramer, and My Sam. We thank Ross Tomaino
(Taplin MS Facility) and John Asara (BIDMC MS Facility) for their
efforts and helpful advice. We also thank Gualtiero Alvisi for helpful
comments on a draft of this article, and for providing a draft of his
accompanying article, and Jennifer Baltz, John Drach, Karen Biron,
Ulrich Koszinowski, Thomas Shenk, Wolfram Brune, Nikolaus Oster-
rieder, Greg Smith, and Robert Kalejta for reagents. We gratefully
acknowledge David Knipe for the use of microscopy facilities and
Lynne Chang for assistancewithmicroscopy and imageprocessing.We
gratefully acknowledge that immunoﬂuorescence data for this study
were analyzed in the Nikon Imaging Center at HarvardMedical School.
References
Alvisi, G., Marin, O., Pari, G., Mancini, M., Avanzi, S., Loregian, A., Jans, D., Ripalti, A., 2011.
Multiple phosphorylation sites at the C-terminus regulate nuclear import of HCMV
DNA polymerase processivity factor ppUL44. Virology 417, 259–267.
Advani, S.J., Weichselbaum, R.R., Roizman, B., 2001. cdc2 cyclin-dependent kinase binds
and phosphorylates herpes simplex virus 1 U(L)42 DNA synthesis processivity
factor. J. Virol. 75, 10326–10333.
Advani, S.J., Weichselbaum, R.R., Roizman, B., 2003. Herpes simplex virus 1 activates
cdc2 to recruit topoisomerase II alpha for post-DNA synthesis expression of late
genes. Proc. Natl. Acad. Sci. U. S. A. 100, 4825–4830.
Ahn, J.H., Jang, W.J., Hayward, G.S., 1999. The human cytomegalovirus IE2 and UL112–
113 proteins accumulate in viral DNA replication compartments that initiate from
the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs
or ND10). J. Virol. 73, 10458–10471.
Alvisi, G., Jans, D.A., Guo, J., Pinna, L.A., Ripalti, A., 2005. A protein kinase CK2 site
ﬂanking the nuclear targeting signal enhances nuclear transport of human
cytomegalovirus ppUL44. Trafﬁc 6, 1002–1013.Alvisi, G., Roth, D.M., Camozzi, D., Pari, G.S., Loregian, A., Ripalti, A., Jans, D.A., 2009. The
ﬂexible loop of the human cytomegalovirus DNA polymerase processivity factor
ppUL44 is required for efﬁcient DNA binding and replication in cells. J. Virol. 83,
9567–9576.
Appleton, B.A., Loregian, A., Filman, D.J., Coen, D.M., Hogle, J.M., 2004. The
cytomegalovirus DNA polymerase subunit UL44 forms a C clamp-shaped dimer.
Mol. Cell 15, 233–244.
Appleton, B.A., Brooks, J., Loregian, A., Filman, D.J., Coen, D.M., Hogle, J.M., 2006. Crystal
structure of the cytomegalovirus DNA polymerase subunit UL44 in complex with
the C terminus from the catalytic subunit. Differences in structure and function
relative to unliganded UL44. J. Biol. Chem. 281, 5224–5232.
Azzeh, M., Honigman, A., Taraboulos, A., Rouvinski, A., Wolf, D.G., 2006. Structural
changes in human cytomegalovirus cytoplasmic assembly sites in the absence of
UL97 kinase activity. Virology 354, 69–79.
Baek, M.C., Krosky, P.M., He, Z., Coen, D.M., 2002. Speciﬁc phosphorylation of exogenous
protein and peptide substrates by the human cytomegalovirus UL97 protein kinase.
Importance of the P+5 position. J. Biol. Chem. 277, 29593–29599.
Baek, M.C., Krosky, P.M., Pearson, A., Coen, D.M., 2004. Phosphorylation of the RNA
polymerase II carboxyl-terminal domain in human cytomegalovirus-infected cells
and in vitro by the viral UL97 protein kinase. Virology 324, 184–193.
Baldick Jr., C.J., Marchini, A., Patterson, C.E., Shenk, T., 1997. Human cytomegalovirus
tegument protein pp 71 (ppUL82) enhances the infectivity of viral DNA and
accelerates the infectious cycle. J. Virol. 71, 4400–4408.
Biron, K.K., 2006. Antiviral drugs for cytomegalovirus diseases. Antiviral Res. 71,
154–163.
Biron, K.K., Harvey, R.J., Chamberlain, S.C., Good, S.S., Smith III, A.A., Davis, M.G., Talarico,
C.L., Miller, W.H., Ferris, R., Dornsife, R.E., Stanat, S.C., Drach, J.C., Townsend, L.B.,
Koszalka, G.W., 2002. Potent and selective inhibition of human cytomegalovirus
replication by 1263 W94, a benzimidazole L-riboside with a unique mode of action.
Antimicrob. Agents Chemother. 46, 2365–2372.
Blom, N., Sicheritz-Ponten, T., Gupta, R., Gammeltoft, S., Brunak, S., 2004. Prediction of
post-translational glycosylation and phosphorylation of proteins from the amino
acid sequence. Proteomics 4, 1633–1649.
Borst, E.M., Hahn, G., Koszinowski, U.H., Messerle, M., 1999. Cloning of the human
cytomegalovirus (HCMV) genome as an infectious bacterial artiﬁcial chromosome
in Escherichia coli: a new approach for construction of HCMV mutants. J. Virol. 73,
8320–8329.
Bresnahan, W.A., Boldogh, I., Chi, P., Thompson, E.A., Albrecht, T., 1997a. Inhibition of
cellular Cdk2 activity blocks human cytomegalovirus replication. Virology 231,
239–247.
Bresnahan,W.A., Thompson, E.A., Albrecht, T., 1997b. Human cytomegalovirus infection
results in altered Cdk2 subcellular localization. J. Gen. Virol. 78, 1993–1997.
Chan, S.R., Chandran, B., 2000. Characterization of human herpesvirus 8 ORF59 protein
(PF-8) and mapping of the processivity and viral DNA polymerase-interacting
domains. J. Virol. 74, 10920–10929.
Chang, C.K., Balachandran, N., 1991. Identiﬁcation, characterization, and sequence
analysis of a cDNA encoding a phosphoprotein of human herpesvirus 6. J. Virol. 65,
2884–2894.
Chou, S., Van Wechel, L.C., Marousek, G.I., 2006. Effect of cell culture conditions on the
anticytomegalovirus activity of maribavir. Antimicrob. Agents Chemother. 50,
2557–2559.
Coulter, L.J.,Moss,H.W., Lang, J.,McGeoch,D.J., 1993. Amutant of herpes simplex virus type
1 in which the UL13 protein kinase gene is disrupted. J. Gen. Virol. 74, 387–395.
de Wind, N., Domen, J., Berns, A., 1992. Herpesviruses encode an unusual protein-
serine/threonine kinase which is nonessential for growth in cultured cells. J. Virol.
66, 5200–5209.
Ertl, P.F., Powell, K.L., 1992. Physical and functional interaction of human cytomega-
lovirus DNA polymerase and its accessory protein (ICP36) expressed in insect cells.
J. Virol. 66, 4126–4133.
Feichtinger, S., Stamminger, T., Muller, R., Graf, L., Klebl, B., Eickhoff, J., Marschall, M.,
2011. Recruitment of cyclin-dependent kinase 9 to nuclear compartments during
cytomegalovirus late replication: importance of an interaction between viral pUL69
and cyclin T1. J. Gen. Virol. 92, 1519–1531.
Fulcher, A.J., Roth, D.M., Fatima, S., Alvisi, G., Jans, D.A., 2009. The BRCA-1 binding
protein BRAP2 is a novel, negative regulator of nuclear import of viral proteins,
dependent on phosphorylation ﬂanking the nuclear localization signal. FASEB J. 24,
1454–1466.
Gao, Y., Colletti, K., Pari, G.S., 2008. Identiﬁcation of human cytomegalovirus UL84 virus-
and cell-encoded binding partners by using proteomics analysis. J. Virol. 82,
96–104.
Gault, E., Michel, Y., Dehee, A., Belabani, C., Nicolas, J.C., Garbarg-Chenon, A., 2001.
Quantiﬁcation of human cytomegalovirus DNA by real-time PCR. J. Clin. Microbiol.
39, 772–775.
Gershburg, E., Pagano, J.S., 2008. Conserved herpesvirus protein kinases. Biochim.
Biophys. Acta 1784, 203–212.
Gershburg, E., Raffa, S., Torrisi, M.R., Pagano, J.S., 2007. Epstein–Barr virus-encoded
protein kinase (BGLF4) is involved in production of infectious virus. J. Virol. 81,
5407–5412.
Gibson, W., 1983. Protein counterparts of human and simian cytomegaloviruses.
Virology 128, 391–406.
Gibson, W., 1984. Synthesis, structure and function of cytomegalovirus major nonvirion
nuclear protein. In: Rapp, F. (Ed.), Herpesvirus: Proceedings of a Burroughs
Wellcome-UCLA Symposium, Held at Steamboat Springs, Colorado, April 8–13,
1984. Alan R. Liss, Inc., New York City, NY, pp. 424–440.
Gibson, W., Murphy, T.L., Roby, C., 1981. Cytomegalovirus-infected cells contain a DNA-
binding protein. Virology 111, 251–262.
279L.A. Silva et al. / Virology 417 (2011) 268–280Goldberg, M.D., Honigman, A., Weinstein, J., Chou, S., Taraboulos, A., Rouvinski, A.,
Shinder, V., Wolf, D.G., 2011. Human cytomegalovirus UL97 kinase and nonkinase
functionsmediate viral cytoplasmic secondary envelopment. J. Virol. 85, 3375–3384.
Hamirally, S., Kamil, J.P., Ndassa-Colday, Y.M., Lin, A.J., Jahng, W.J., Baek, M.C., Noton, S.,
Silva, L.A., Simpson-Holley, M., Knipe, D.M., Golan, D.E., Marto, J.A., Coen, D.M., 2009.
Viral mimicry of Cdc2/cyclin-dependent kinase 1 mediates disruption of nuclear
lamina during human cytomegalovirus nuclear egress. PLoS Pathog. 5, e1000275.
Hanﬂer, J., Kreuzer, K.A., Laurisch, K., Rayes, N., Neuhaus, P., Schmidt, C.A., Oettle, H.,
2003. Quantitation of cytomegalovirus (hCMV) DNA and beta-actin DNA by duplex
real-time ﬂuorescence PCR in solid organ (liver) transplant recipients. Med.
Microbiol. Immunol. 192, 197–204.
He, Z., He, Y.S., Kim, Y., Chu, L., Ohmstede, C., Biron, K.K., Coen, D.M., 1997. The human
cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on
serines and threonines. J. Virol. 71, 405–411.
Heald, R., McKeon, F., 1990. Mutations of phosphorylation sites in lamin A that prevent
nuclear lamina disassembly in mitosis. Cell 61, 579–589.
Heineman, T.C., Cohen, J.I., 1995. The varicella-zoster virus (VZV) open reading frame
47 (ORF47) protein kinase is dispensable for viral replication and is not required for
phosphorylation of ORF63 protein, the VZV homolog of herpes simplex virus ICP22.
J. Virol. 69, 7367–7370.
Hertel, L., Chou, S., Mocarski, E.S., 2007. Viral and cell cycle-regulated kinases in
cytomegalovirus-induced pseudomitosis and replication. PLoS Pathog. 3, e6.
Hobom, U., Brune, W., Messerle, M., Hahn, G., Koszinowski, U.H., 2000. Fast screening
procedures for random transposon libraries of cloned herpesvirus genomes:
mutational analysis of human cytomegalovirus envelope glycoprotein genes.
J. Virol. 74, 7720–7729.
Hume, A.J., Finkel, J.S., Kamil, J.P., Coen, D.M., Culbertson, M.R., Kalejta, R.F., 2008.
Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent
kinase function. Science 320, 797–799.
Isomura, H., Stinski, M.F., Kudoh, A., Nakayama, S., Iwahori, S., Sato, Y., Tsurumi, T., 2007.
The late promoter of the human cytomegalovirus viral DNA polymerase
processivity factor has an impact on delayed early and late viral gene products
but not on viral DNA synthesis. J. Virol. 81, 6197–6206.
Isomura, H., Stinski, M.F., Kudoh, A., Murata, T., Nakayama, S., Sato, Y., Iwahori, S.,
Tsurumi, T., 2008. Noncanonical TATA sequence in the UL44 late promoter of
human cytomegalovirus is required for the accumulation of late viral transcripts.
J. Virol. 82, 1638–1646.
Jacob, T., Van den Broeke, C., Favoreel, H.W., 2011. Viral serine/threonine protein
kinases. J. Virol. 85, 1158–1173.
Kamil, J.P., Coen, D.M., 2007. Human cytomegalovirus protein kinase UL97 forms a
complex with the tegument phosphoprotein pp 65. J. Virol. 81, 10659–10668.
Kamil, J.P., Hume, A.J., Jurak, I., Munger, K., Kalejta, R.F., Coen, D.M., 2009. Human
papillomavirus 16 E7 inactivator of retinoblastoma family proteins complements
human cytomegalovirus lacking UL97 protein kinase. Proc. Natl. Acad. Sci. U. S. A.
106, 16823–16828.
Kapasi, A.J., Spector, D.H., 2008. Inhibition of the cyclin-dependent kinases at the
beginning of human cytomegalovirus infection speciﬁcally alters the levels and
localization of the RNA polymerase II carboxyl-terminal domain kinases cdk9 and
cdk7 at the viral transcriptosome. J. Virol. 82, 394–407.
Kawaguchi, Y., Kato, K., 2003. Protein kinases conserved in herpesviruses potentially
share a function mimicking the cellular protein kinase cdc2. Rev. Med. Virol. 13,
331–340.
Kawaguchi, Y., Matsumura, T., Roizman, B., Hirai, K., 1999. Cellular elongation factor
1delta is modiﬁed in cells infected with representative alpha-, beta-, or
gammaherpesviruses. J. Virol. 73, 4456–4460.
Kawaguchi, Y., Kato, K., Tanaka, M., Kanamori, M., Nishiyama, Y., Yamanashi, Y., 2003.
Conserved protein kinases encoded by herpesviruses and cellular protein kinase
cdc2 target the same phosphorylation site in eukaryotic elongation factor 1delta.
J. Virol. 77, 2359–2368.
Kim, Y.E., Ahn, J.H., 2010. Role of the speciﬁc interaction of UL112–113 p84 with UL44
DNA polymerase processivity factor in promoting DNA replication of human
cytomegalovirus. J. Virol. 84, 8409–8421.
Krosky, P.M., Baek, M.-C., Coen, D.M., 2003a. The human cytomegalovirus UL97 protein
kinase, an antiviral drug target, is required at the stage of nuclear egress. J. Virol. 77,
905–914.
Krosky, P.M., Baek, M.C., Jahng, W.J., Barrera, I., Harvey, R.J., Biron, K.K., Coen, D.M.,
Sethna, P.B., 2003b. The human cytomegalovirus UL44 protein is a substrate for the
UL97 protein kinase. J. Virol. 77, 7720–7727.
Kuny, C.V., Chinchilla, K., Culbertson, M.R., Kalejta, R.F., 2010. Cyclin-dependent kinase-
like function is shared by the beta- and gamma-subset of the conserved herpesvirus
protein kinases. PLoS Pathog. 6, e1001092.
Littler, E., Stuart, A.D., Chee, M.S., 1992. Human cytomegalovirus UL97 open reading
frame encodes a protein that phosphorylates the antiviral nucleoside analogue
ganciclovir. Nature 358, 160–162.
Loregian, A., Appleton, B.A., Hogle, J.M., Coen, D.M., 2004a. Residues of human
cytomegalovirus DNA polymerase catalytic subunit UL54 that are necessary and
sufﬁcient for interaction with the accessory protein UL44. J. Virol. 78, 158–167.
Loregian, A., Appleton, B.A., Hogle, J.M., Coen, D.M., 2004b. Speciﬁc residues in the
connector loop of the human cytomegalovirus DNA polymerase accessory protein
UL44 are crucial for interactionwith theUL54catalytic subunit. J. Virol. 78, 9084–9092.
Marschall, M., Freitag, M., Suchy, P., Romaker, D., Kupfer, R., Hanke, M., Stamminger, T.,
2003. The protein kinase pUL97 of human cytomegalovirus interacts with and
phosphorylates the DNA polymerase processivity factor pUL44. Virology 311, 60–71.
Marsden, H.S., Campbell, M.E., Haarr, L., Frame, M.C., Parris, D.S., Murphy, M., Hope, R.G.,
Muller, M.T., Preston, C.M., 1987. The 65,000-Mr DNA-binding and virion trans-
inducing proteins of herpes simplex virus type 1. J. Virol. 61, 2428–2437.Meijer, L., Raymond, E., 2003. Roscovitine and other purines as kinase inhibitors. From
starﬁsh oocytes to clinical trials. Acc. Chem. Res. 36, 417–425.
Meijer, L., Borgne, A., Mulner, O., Chong, J.P., Blow, J.J., Inagaki, N., Inagaki, M., Delcros,
J.G., Moulinoux, J.P., 1997. Biochemical and cellular effects of roscovitine, a potent
and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur.
J. Biochem. 243, 527–536.
Meisenhelder, J., 1999. Phosphopeptide mapping and identiﬁcation of phosphorylation
sites. Curr. Protoc. Protein Sci. 13.19.19-13.19.10.
Mercorelli, B., Sinigalia, E., Loregian, A., Palu, G., 2008. Human cytomegalovirus DNA
replication: antiviral targets and drugs. Rev. Med. Virol. 18, 177–210.
Michel, D., Mertens, T., 2004. The UL97 protein kinase of human cytomegalovirus and
homologues in other herpesviruses: impact on virus and host. Biochim. Biophys.
Acta 1697, 169–180.
Mocarski, E.S., Shenk, T., Pass, R.F., 2007. Cytomegaloviruses, In: Fields, B.N., Knipe, D.M.,
Howley, P.M. (Eds.), Fields Virology, 5th ed. Lippincott Williams & Wilkins,
Philadelphia, pp. 2701–2772.
Moffat, J.F., Zerboni, L., Sommer, M.H., Heineman, T.C., Cohen, J.I., Kaneshima, H., Arvin,
A.M., 1998. The ORF47 and ORF66 putative protein kinases of varicella-zoster virus
determine tropism for human T cells and skin in the SCID-hu mouse. Proc. Natl.
Acad. Sci. U. S. A. 95, 11969–11974.
Ohashi, M., Horie, K., Hoshikawa, Y., Nagata, K., Osaki, M., Ito, H., Sairenji, T., 2007.
Accumulation of Epstein–Barr virus (EBV) BMRF1 protein EA-D during latent EBV
activation of Burkitt's lymphoma cell line Raji. Microbes Infect. 9, 150–159.
Penfold,M.E.,Mocarski, E.S., 1997. Formationof cytomegalovirusDNA replication compart-
ments deﬁnedby localizationof viral proteins andDNAsynthesis. Virology239, 46–61.
Peter, M., Nakagawa, J., Doree, M., Labbe, J.C., Nigg, E.A., 1990. In vitro disassembly of the
nuclear lamina andM phase-speciﬁc phosphorylation of lamins by cdc2 kinase. Cell
61, 591–602.
Prichard, M.N., Gao, N., Jairath, S., Mulamba, G., Krosky, P., Coen, D.M., Parker, B.O., Pari,
G.S., 1999. A recombinant human cytomegalovirus with a large deletion in UL97
has a severe replication deﬁciency. J. Virol. 73, 5663–5670.
Prichard, M.N., Britt, W.J., Daily, S.L., Hartline, C.B., Kern, E.R., 2005. Human
cytomegalovirus UL97 Kinase is required for the normal intranuclear distribution
of pp 65 and virion morphogenesis. J. Virol. 79, 15494–15502.
Prichard, M.N., Sztul, E., Daily, S.L., Perry, A.L., Frederick, S.L., Gill, R.B., Hartline, C.B.,
Streblow, D.N., Varnum, S.M., Smith, R.D., Kern, E.R., 2008. Human cytomegalovirus
UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma
protein and inhibits the formation of nuclear aggresomes. J. Virol. 82, 5054–5067.
Rechter, S., Scott, G.M., Eickhoff, J., Zielke, K., Auerochs, S., Muller, R., Stamminger, T.,
Rawlinson, W.D., Marschall, M., 2009. Cyclin-dependent kinases phosphorylate the
cytomegalovirus RNA export protein pUL69 and modulate its nuclear localization
and activity. J. Biol. Chem. 284, 8605–8613.
Roeckel, D., Mueller-Lantzsch, N., 1985. Biochemical characterization of two Epstein–
Barr virus early antigen-associated phosphopolypeptides. Virology 147, 253–263.
Romaker, D., Schregel, V., Maurer, K., Auerochs, S., Marzi, A., Sticht, H., Marschall, M.,
2006. Analysis of the structure–activity relationship of four herpesviral UL97
subfamily protein kinases reveals partial but not full functional conservation.
J. Med. Chem. 49, 7044–7053.
Saffert, R.T., Kalejta, R.F., 2007. Human cytomegalovirus gene expression is silenced by
Daxx-mediated intrinsic immune defense in model latent infections established in
vitro. J. Virol. 81, 9109–9120.
Sanchez, V., Spector, D.H., 2006. Cyclin-dependent kinase activity is required for
efﬁcient expression and posttranslational modiﬁcation of human cytomegalovirus
proteins and for production of extracellular particles. J. Virol. 80, 5886–5896.
Sanchez, V., McElroy, A.K., Spector, D.H., 2003. Mechanisms governing maintenance of
Cdk1/cyclin B1 kinase activity in cells infected with human cytomegalovirus.
J. Virol. 77, 13214–13224.
Sanchez,V.,McElroy,A.K., Yen, J., Tamrakar, S., Clark, C.L., Schwartz, R.A., Spector,D.H., 2004.
Cyclin-dependent kinase activity is required at early times for accurate processing
and accumulation of the human cytomegalovirus UL122–123 and UL37 immediate-
early transcripts and at later times for virus production. J. Virol. 78, 11219–11232.
Sanchez, V., Mahr, J.A., Orazio, N.I., Spector, D.H., 2007. Nuclear export of the human
cytomegalovirus tegument protein pp 65 requires cyclin-dependent kinase activity
and the Crm1 exporter. J. Virol. 81, 11730–11736.
Silva, L.A., Loregian, A., Pari, G.S., Strang, B.L., Coen, D.M., 2010. The carboxy-terminal
segment of the human cytomegalovirus DNA polymerase accessory subunit UL44 is
crucial for viral replication. J. Virol. 84, 11563–11568.
Strang, B.L., Sinigalia, E., Silva, L.A., Coen, D.M., Loregian, A., 2009. Analysis of the
association of the human cytomegalovirus DNA polymerase subunit UL44 with the
viral DNA replication factor UL84. J. Virol. 83, 7581–7589.
Strang, B.L., Boulant, S., Coen, D.M., 2010a. Nucleolin associates with the human
cytomegalovirus DNA polymerase accessory subunit UL44 and is necessary for
efﬁcient viral replication. J. Virol. 84, 1771–1784.
Strang, B.L., Geballe, A.P., Coen, D.M., 2010b. Association of human cytomegalovirus
proteins IRS1 and TRS1 with the viral DNA polymerase accessory subunit UL44.
J. Gen. Virol. 91, 2167–2175.
Sullivan, V., Talarico, C.L., Stanat, S.C., Davis, M., Coen, D.M., Biron, K.K., 1992. A protein
kinase homologue controls phosphorylation of ganciclovir in human cytomegalo-
virus-infected cells. Nature 358, 162–164.
Talarico, C.L., Burnette, T.C., Miller, W.H., Smith, S.L., Davis, M.G., Stanat, S.C., Ng, T.I., He, Z.,
Coen, D.M., Roizman, B., Biron, K.K., 1999. Acyclovir is phosphorylated by the human
cytomegalovirus UL97 protein. Antimicrob. Agents Chemother. 43, 1941–1946.
Tamrakar, S., Kapasi, A.J., Spector, D.H., 2005. Human cytomegalovirus infection induces
speciﬁc hyperphosphorylation of the carboxyl-terminal domain of the large
subunit of RNA polymerase II that is associated with changes in the abundance,
activity, and localization of cdk9 and cdk7. J. Virol. 79, 15477–15493.
280 L.A. Silva et al. / Virology 417 (2011) 268–280Tanaka, M., Nishiyama, Y., Sata, T., Kawaguchi, Y., 2005. The role of protein kinase
activity expressed by the UL13 gene of herpes simplex virus 1: the activity is not
essential for optimal expression of UL41 and ICP0. Virology 341, 301–312.
Tischer, B.K., von Einem, J., Kaufer, B., Osterrieder, N., 2006. Two-step red-mediated
recombination for versatile high-efﬁciency markerless DNA manipulation in
Escherichia coli. Biotechniques 40, 191–197.
Trofe, J., Pote, L., Wade, E., Blumberg, E., Bloom, R.D., 2008. Maribavir: a novel antiviral
agent with activity against cytomegalovirus. Ann. Pharmacother. 42, 1447–1457.
Wang, J.T., Yang, P.W., Lee, C.P., Han, C.H., Tsai, C.H., Chen, M.R., 2005. Detection of
Epstein–Barr virus BGLF4 protein kinase in virus replication compartments and
virus particles. J. Gen. Virol. 86, 3215–3225.Ward, G.E., Kirschner, M.W., 1990. Identiﬁcation of cell cycle-regulated phosphoryla-
tion sites on nuclear lamin C. Cell 61, 561–577.
Weiland, K.L., Oien, N.L., Homa, F., Wathen, M.W., 1994. Functional analysis of human
cytomegalovirus polymerase accessory protein. Virus Res. 34, 191–206.
West, M.H.P., Wu, R.S., Bonner, W.M., 1984. Polyacrylamide gel electrophoresis of small
peptides. Electrophoresis 5, 133–138.
Wolf, D.G., Courcelle, C.T., Prichard, M.N., Mocarski, E.S., 2001. Distinct and separate
roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and
encapsidation. Proc. Natl. Acad. Sci. U. S. A. 98, 1895–1900.
Zydek, M., Hagemeier, C., Wiebusch, L., 2010. Cyclin-dependent kinase activity controls
the onset of the HCMV lytic cycle. PLoS Pathog. 6, e1001096.
